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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 2-2.5 hours of work and is not intended to be a comprehensive 
summary of evidence. 
Report 13: Estimating the number of infections and the impact of non-pharmaceutical 
interventions on COVID-19 in 11 European countries 
Flaxman, S., Mishra, S. Gandy, A. et al. | Imperial College COVID-19 Response Team | 30 
March 2020 | Report 
https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-
College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf 
Authors estimate that countries have managed to reduce their reproduction number. Across all 11 
European countries and with current interventions in place to 31 March, 59 000 [95% credible 
interval 21 000-120 000] deaths are estimated to have been averted. By ensuring that interventions 
remain in place until transmission drops to low levels, many more will be averted. Between 7 and 
43 million people are estimated to have been infected with SARS-CoV-2 up to 28 March, 
representing between 1.88% and 11.43% of the population. For most of the countries considered 
it remains too early to be certain that recent interventions have been effective given the lag of 2 to 
3 weeks between when transmission changes occur and when their impact can be observed in 
trends in mortality. Estimates will change accordingly. Current interventions must remain in place 
and trends in cases and deaths monitored to reassure that transmission of SARS-CoV-2 is slowing. 
We know how long coronavirus survives on surfaces. Here’s what is means for handling 
money, food and more 
Mackay, A.M. & Arden, K. | The Conversation | 30 March 2020 | News article 
https://theconversation.com/we-know-how-long-coronavirus-survives-on-surfaces-heres-what-it-
means-for-handling-money-food-and-more-134671 
Contains a useful image on ‘How long does coronavirus survive on surfaces?’ 
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AIDS, TB and Malaria: Coronavirus threatens the endgame 
Pai, M. | Forbes | 29 March 2020 |  
https://www.forbes.com/sites/madhukarpai/2020/03/29/aids-tb-and-malaria-coronavirus-
threatens-the-endgame/ 
Is the SDG goal to end the epidemics of AIDS, TB and malaria by 2030 still achievable given the 
coronavirus pandemic? Pai captures his interviews with several global leaders and from agencies 
dedicated to AIDS, TB and malaria including Peter Sands, Director of the Global Fund; Winnie 
Byanyima, Director of UNAIDS; Pedro Alonso, Director of the WHO Global Malaria Programme; 
Joanne Liu, former president of MSF; Tereza Kasaeva, Director of the WHO Global TB 
Programme.  
Epidemic preparedness in urban settings: new challenges and opportunities 
Lee et al. | 27 March 2020 | The Lancet Infectious Diseases | Comment 
https://doi.org/10.1016/S1473-3099(20)30249-8 
Includes a Table on the challenges, and opportunities for epidemic preparedness associated with 
characteristics of urban settings. 
Q&A: Access to health services is key to halting COVID-19 and saving refugee lives 
Clayton, J. | UNHCR | 27 March 2020 | News 
https://www.unhcr.org/uk/news/latest/2020/3/5e7dab2c4/qa-access-health-services-key-halting-
covid-19-saving-refugee-lives.html 
The dangers of COVID-19 to refugees and internally displaced people is outlined by Ann Burton, 
Chief of UNHCR’s Public Health Section, and she describes how the agency is working to slow its 
spread, reduce its impact and save lives. 
A framework for rationing ventilators and critical care beds during the COVID-19 
pandemic  
White, D. and Lo, B. | JAMA | 27 March 2020 | Viewpoint 
https://doi.org/10.1001/jama.2020.5046 
This viewpoint considers ethical concerns when demand for ventilators and other intensive 
treatments outnumber supply, what criteria should guide these rationing decisions and a proposal 
for a “framework for making allocation decision that incorporates multiple ethically relevant 
considerations, whilst allowing all patients in need to be eligible for access to critical care”.  
WHO Director-General’s opening remarks at the media briefing on COVID-19 – 27 March 
2020 
https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-
briefing-on-covid-19---27-march-2020 
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WHO | 27 March 2020 | Media briefing 
The WHO Solidarity Trial has enrolled its first patient in Norway and shortly in Spain. This multi-
centre, adaptive, randomised, open clinical trial will evaluate and compare the safety and efficacy 
of four different drugs or drug combinations against COVID-19 with standard care in hospitalised 
patients diagnosed with COVID-19. The trial started on 26 March and will continue until November 
2020 recruiting up to 700 participants. Forty-five countries are involved, and more have expressed 
interest. In the meantime, the WHO DG calls on individuals and countries to refrain from using 
therapeutics that have not been demonstrated to be effective in the treatment of COVID-19. 
Learning from the Ebola epidemic where some medicines thought to be effective were found not 
be as effective as others when compared during a clinical trial - drug treatment must be evidence 
informed. Also, we need to ensure that using unproven drugs does not create a shortage of those 
medicines to treat diseases for which they have proven effective. 
COVID-10 Research in Brief: 20 March to 27 March 2020 
Carvalho T | Nature Medicine | 27 March 2020 | News 
https://do.org/10.1038/d41591-020-00006-0 
Nature Medicine summaries COVID-19 research on clinical trials, serology, preclinical studies, 
viral origin and structure from this week. 
Open health facility location data for Africa to support COVID-19 efforts 
South A. & van der Walt A | Afrimapr | 26 March 2020 | Data 
https://afrimapr.github.io/afrimapr.website/blog/2020/healthsites-app/ 
The afrimapr approach aims to improve access to the best-available health facility data for Africa 
to support the response to the coronavirus pandemic, for example, in COVID Care Map, an open 
source project to support health system capacity (beds, staffing, ventilators, supplies) which is 
currently USA-centric but intends to become globally applicable. This approach is currently drawing 
on two datasets – a spatial database of health facilities managed by the public health sector in 
SSA now curated by the WHO Global Malaria Program and a dataset from the global project 
healthsites.io – but welcome input on other potential data sources or how it would be useful to 
improve these tools. 
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: a 
retrospective study 
Chen et al. | BMJ | 26 March 2020 | Article 
https://doi.org/10.1136/bmj.m1091 
This retrospective case series of 113 who died among a cohort of 799 patients diagnosed with 
COVID-19 (data collected until 28 February 2020) found that SARS-CoV-2 can cause both 
pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk. 
The most common critical complications were acute respiratory distress syndrome and respiratory 
failure, sepsis, acute cardiac injury, and heart failure. 
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The effect of human mobility and control measures on the COVID-19 epidemic in China 
Kraemer et al. | Science | 25 March 2020 | Article 
https://doi.org/10.1126/science.abb4218 
This study shows that the combination of control measures implemented in China, including travel 
restrictions, substantially mitigated the spread of COVID-19. Using real-time mobility data from 
Wuhan and detailed case data including travel history, this study shows that travel restrictions are 
useful in the early stage of an outbreak when it is confined to a certain area that acts as a major 
source but less effective once the outbreak is more widespread. It was not possible in this study 
to definitively determine the impact of each intervention and more work is required on how to 
optimally balance expected positive effect on public health with the negative effect on movement, 
the economy and society in general.  
COVID-19 – the social science response to the pandemic 
IDS | 23 March 2020 | News 
https://www.ids.ac.uk/news/covid-19-the-social-science-response-to-the-pandemic/ 
A useful summary linking to opinion pieces from social scientists, including those from IDS, working 
to respond to COVID-19. Includes links to drawing on lessons from Ebola, SARS and the initial 
outbreak in Wuhan; the importance of pandemic responses from ‘bottom-up’; COVID-19 and 
Africa; understanding the impacts on people in slums and informal settlements; impact on informal 
work; importance of connecting policy networks; and COVID-19 and religious practices.  
1. Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
An interactive web-based dashboard to track COVID-19 in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467
b48e9ecf6 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected countries 
http://globalhealth5050.org/covid19 
Africa 
Africa Centres for Disease Control and Prevention (Africa CDC) 
http://www.africacdc.org/covid-19-and-resources 
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Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
South African Government COVID-19 
https://www.gov.za/Coronavirus 
UK 
COVID-19: PHE track coronavirus cases in the UK 
https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases 
UK case tracing infographic 
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4bb14 
2. Online course 
Responding to COVID-19: Real-time training for the coronavirus disease outbreak 
WHO | Available now | multiple self-paced courses 
https://openwho.org/channels/covid-19 
Note that courses are available in English and other languages including French, Portuguese 
and Spanish. 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
6 
3. Resource Hubs 
Coronavirus: the science explained 
https://coronavirusexplained.ukri.org/en/ 
Social Science in Humanitarian Action: Updates on the novel COVID-19 outbreak 
https://www.socialscienceinaction.org/update-novel-covid-19-outbreak/ 
Special Collection: Coronavirus (COVID-19): evidence relevant to critical care 
https://www.cochrane.org/news/special-collection-coronavirus-covid-19-evidence-relevant-
critical-care 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-
coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.html 
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The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campaign=
DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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